
Challenge
Adam came to us with a tight deadline - a 10-minute pitch in front of 50 LPs from healthcare systems, insurance companies, and diagnostic labs at a BlueCross BlueShield Sandbox event - and needed both a pitch deck and a one-pager that could open partnership conversations rather than close a hard investment ask.
Solution
We built the full pitch deck and investor one-pager across multiple fast revision rounds - restructuring the content flow, designing the partnership opportunities slide as the centerpiece of the deck, building out a clean vision diagram of Geneial's data network, and delivering an 8.5"x11" one-pager formatted for professional distribution at the event.
Results
Adam walked into the BCBS Sandbox event with a polished, partnership-focused deck and one-pager - ready to open conversations with healthcare systems, payers, labs, and biopharma companies in the room.
Biotech
Artificial Intelligence
Building the Deck for Geneial's BCBS Sandbox Pitch
Geneial is an NIH-funded, HIPAA-compliant rare disease registry and precision medicine platform - combining Bridge (a generative AI data standardization engine) and Advocate (a patient engagement and consent platform) to help payers, providers, and biopharma securely collect, standardize, and act on patient health data at scale. Founded by Dr. Adam Hansen (NIH Principal Investigator and geneticist) and Chris Hansen (data security expert, multiple patents), Geneial targets the structural gap in healthcare data where fragmented EHRs, privacy constraints, and engagement failures leave critical patient insights uncaptured.
"This is excellent, thank you Giorgi!!"

Adam Hansen
.jpg)
NIH
Principal Investigator-Founded Company
10+
Team Members Including 3 PhDs, 3 Ex-Founders, 3 Successful Exits
2
Deliverables Built (Pitch Deck + One-Pager)